LPCN
Lipocine IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$18.63M
P/E Ratio
—
EPS
$-1.96
Beta
0.50
52W High
$12.37
52W Low
$1.81
50-Day MA
$3.77
200-Day MA
$4.75
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
5.64
PEG Ratio
0.00
About Lipocine Inc
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceuticals for the treatment of metabolic and endocrine disorders. The company is headquartered in Salt Lake City, Utah.
Fundamentals
| Revenue (TTM) | $2.00M |
| Gross Profit (TTM) | $2.00M |
| EBITDA | $-12.07M |
| Operating Margin | -3224.00% |
| Return on Equity | -54.40% |
| Return on Assets | -33.10% |
| Revenue/Share (TTM) | $0.34 |
| Book Value | $2.35 |
| Price-to-Book | 0.82 |
| Price-to-Sales (TTM) | 9.31 |
| EV/Revenue | 2.353 |
| EV/EBITDA | 153.43 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 27.20% |
| Shares Outstanding | $8.24M |
| Float | $6.88M |
| % Insiders | 4.51% |
| % Institutions | 44.29% |
Analyst Ratings
Consensus ($6.00 target)
1
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026